During the past decade, University of Fukui Hospital conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 12 clinical trials were completed, i.e. on average, 32.4% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 11 clinical trials were completed. i.e. 55% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Fukui Hospital" #1 sponsor was "Janssen Pharmaceutical K.K." with 4 trials, followed by "Amgen" with 3 trials sponsored, "Ferring Pharmaceuticals" with 3 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 3 trials sponsored and "Bayer" with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Fukui Hospital" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator, "Alpha-A, Inc." with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Japan Agency for Medical Research and Development" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "University of Fukui Hospital" are "Acute Myeloid Leukemia" (6 trials), "Leukemia, Myeloid, Acute" (6 trials), "Myelodysplastic Syndrome" (3 trials), "Nocturia" (3 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "University of Fukui Hospital" in a lesser frequency.

Most popular intervention types in "University of Fukui Hospital" are "Drug" (42 trials), "Procedure" (3 trials), "Device" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Azacitidine" (6 trials), "Cytarabine" (4 trials), "Daunorubicin" (2 trials) and "UFT adjuvant chemotherapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Fukui Hospital" are 44 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "University of Fukui Hospital". undefined are not yet recruiting, 9 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in University of Fukui Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University of Fukui Hospital, 9 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".